These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31495331)

  • 21. Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial.
    McIntyre LA; Stewart DJ; Mei SHJ; Courtman D; Watpool I; Granton J; Marshall J; Dos Santos C; Walley KR; Winston BW; Schlosser K; Fergusson DA; ;
    Am J Respir Crit Care Med; 2018 Feb; 197(3):337-347. PubMed ID: 28960096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.
    Hare JM; Traverse JH; Henry TD; Dib N; Strumpf RK; Schulman SP; Gerstenblith G; DeMaria AN; Denktas AE; Gammon RS; Hermiller JB; Reisman MA; Schaer GL; Sherman W
    J Am Coll Cardiol; 2009 Dec; 54(24):2277-86. PubMed ID: 19958962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
    Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
    Guekht A; Skoog I; Edmundson S; Zakharov V; Korczyn AD
    Stroke; 2017 May; 48(5):1262-1270. PubMed ID: 28432265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
    Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
    Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial.
    Jaillard A; Hommel M; Moisan A; Zeffiro TA; Favre-Wiki IM; Barbieux-Guillot M; Vadot W; Marcel S; Lamalle L; Grand S; Detante O;
    Transl Stroke Res; 2020 Oct; 11(5):910-923. PubMed ID: 32462427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.
    Honmou O; Houkin K; Matsunaga T; Niitsu Y; Ishiai S; Onodera R; Waxman SG; Kocsis JD
    Brain; 2011 Jun; 134(Pt 6):1790-807. PubMed ID: 21493695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Individualized Coaching After Stroke: the LAST Study (Life After Stroke): A Pragmatic Randomized Controlled Trial.
    Askim T; Langhammer B; Ihle-Hansen H; Gunnes M; Lydersen S; Indredavik B;
    Stroke; 2018 Feb; 49(2):426-432. PubMed ID: 29284737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke: A Neuroimaging Study.
    Lee J; Chang WH; Chung JW; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH; Bang OY;
    Stroke; 2022 Jan; 53(1):20-28. PubMed ID: 34583525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Dextroamphetamine on Poststroke Motor Recovery: A Randomized Clinical Trial.
    Goldstein LB; Lennihan L; Rabadi MJ; Good DC; Reding MJ; Dromerick AW; Samsa GP; Pura J
    JAMA Neurol; 2018 Dec; 75(12):1494-1501. PubMed ID: 30167675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial.
    Álvaro-Gracia JM; Jover JA; García-Vicuña R; Carreño L; Alonso A; Marsal S; Blanco F; Martínez-Taboada VM; Taylor P; Martín-Martín C; DelaRosa O; Tagarro I; Díaz-González F
    Ann Rheum Dis; 2017 Jan; 76(1):196-202. PubMed ID: 27269294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke.
    Laskowitz DT; Troy J; Poehlein E; Bennett ER; Shpall EJ; Wingard JR; Freed B; Belagaje SR; Khanna A; Jones W; Volpi JJ; Marrotte E; Kurtzberg J
    Stem Cells Transl Med; 2024 Feb; 13(2):125-136. PubMed ID: 38071749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study.
    Laskowitz DT; Bennett ER; Durham RJ; Volpi JJ; Wiese JR; Frankel M; Shpall E; Wilson JM; Troy J; Kurtzberg J
    Stem Cells Transl Med; 2018 Jul; 7(7):521-529. PubMed ID: 29752869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.
    Yau TM; Pagani FD; Mancini DM; Chang HL; Lala A; Woo YJ; Acker MA; Selzman CH; Soltesz EG; Kern JA; Maltais S; Charbonneau E; Pan S; Marks ME; Moquete EG; O'Sullivan KL; Taddei-Peters WC; McGowan LK; Green C; Rose EA; Jeffries N; Parides MK; Weisel RD; Miller MA; Hung J; O'Gara PT; Moskowitz AJ; Gelijns AC; Bagiella E; Milano CA;
    JAMA; 2019 Mar; 321(12):1176-1186. PubMed ID: 30912838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell therapy: a clinical trial of stroke.
    Bhasin A; Srivastava MV; Mohanty S; Bhatia R; Kumaran SS; Bose S
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1003-8. PubMed ID: 23183251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic adipose tissue-derived mesenchymal stem cells in ischaemic stroke (AMASCIS-02): a phase IIb, multicentre, double-blind, placebo-controlled clinical trial protocol.
    de Celis-Ruiz E; Fuentes B; Moniche F; Montaner J; Borobia AM; Gutiérrez-Fernández M; Díez-Tejedor E
    BMJ Open; 2021 Aug; 11(8):e051790. PubMed ID: 34373315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Outcomes in Patients Aged ≤70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis.
    Sheth KN; Petersen NH; Cheung K; Elm JJ; Hinson HE; Molyneaux BJ; Beslow LA; Sze GK; Simard JM; Kimberly WT
    Stroke; 2018 Jun; 49(6):1457-1463. PubMed ID: 29789393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.
    Lublin FD; Bowen JD; Huddlestone J; Kremenchutzky M; Carpenter A; Corboy JR; Freedman MS; Krupp L; Paulo C; Hariri RJ; Fischkoff SA
    Mult Scler Relat Disord; 2014 Nov; 3(6):696-704. PubMed ID: 25891548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.